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The measurement properties of the Spence Children’s Anxiety Scale- Parent version in 
a large international pooled sample of young people with Autism Spectrum Disorder 
Lay Abstract 
Young people with ASD are often affected by anxiety. Assessing and measuring anxiety in 
ASD reliably and accurately is challenging, as research has yet to identify which existing 
anxiety measures are most useful and relevant when used with youth with ASD. The present 
study examined the measurement properties and factor structure of the Spence Children’s 
Anxiety Scale-Parent Version (SCAS-P) in a large international pooled sample of youth with 
ASD. Data from 870 participants from 12 studies in the UK, USA and Singapore were 
pooled. The accuracy of the existing SCAS-P full scale and its subscales was as good as that 
reported in typically developing children. The subscale measuring fear of animals, insects, 
environment and doctors, however, had poor accuracy. Thirty items out of the existing 38 
SCAS-P items were identified to measure anxiety more accurately than the existing SCAS-P, 
but the way these items were organized together into subtypes was different to the anxiety 
subtypes commonly found in typically developing children. Moreover, these subscales were 
not consistent in one half compared to the other half of this large sample. The limitations of 
the present study, the use of SCAS-P to screen for anxiety problems in ASD and future 
research directions are discussed.  
 
Scientific Abstract 
Anxiety-related difficulties are common in ASD, but measuring anxiety reliably and validly is 
challenging. Despite an increasing number of studies, there is no clear agreement on which 
existing anxiety measure is more psychometrically sound and what is the factor structure of 
anxiety in ASD. The present study examined the internal consistency, convergent, divergent 
and discriminant validity, as well as the factor structure of the Spence Children’s Anxiety 
Scale-Parent Version (SCAS-P), in a large international pooled sample of 870 caregivers of 
youth with ASD from 12 studies in the UK, USA and Singapore who completed the SCAS-P. 
Most were community recruited, while the majority had at least one measure of ASD 
symptomatology and either cognitive or adaptive functioning measures completed. Existing 
SCAS-P total scale and subscales had excellent internal consistency and good convergent, 
divergent and discriminant validity similar to or better than SCAS-P properties reported in 
typically developing children, except for the poorer internal consistency of the physical injury 
subscale. Confirmatory Factor Analysis (CFA) of the existing SCAS-P six-correlated factor 
structure was a poor fit for this pooled database. Principal component analysis using half of the 
pooled sample identified a 30-item five correlated factor structure, but a CFA of this PCA-
derived structure in the second half of this pooled sample revealed a poor fit, although the PCA-
derived SCAS-P scale and subscales had stronger validity and better internal consistency than 
the original SCAS-P. The study’s limitations, the use of the SCAS-P to screen for DSM-derived 
anxiety problems in ASD and future research directions are discussed.  
 
Key Words: autism spectrum disorder, anxiety, parent report, measurement, assessment, 
reliability, validity, factor structure. 
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The measurement properties of the Spence Children’s Anxiety Scale- Parent version in 
a large international pooled sample of young people with Autism Spectrum Disorder 
Introduction 
Individuals with ASD have significantly higher rates of clinically elevated anxiety 
symptoms (10-84%) or diagnosed anxiety disorders (about 40%) compared to individuals 
without ASD or with other conditions (van Steensel et al., 2011; White et al., 2009). Anxiety-
related difficulties can significantly interfere with and negatively impact development, 
functioning and quality of life in ASD (Davis III et al., 2014; Pellecchia et al., 2016). 
However, the identification and measurement of anxiety in ASD is often complex and 
challenging.  
 Emerging evidence suggests people with ASD experience both “typical” anxiety (i.e.  
worries about separation, achievement or social evaluation, common specific phobias) as well 
as more idiosyncratic anxiety presentations more specifically relating to ASD (i.e., worries 
about change, specific sensory related fears; social anxiety without fear of negative 
evaluation; see Ozsivadjian et al., 2012; Kerns et al., 2014; Trembath et al., 2012; Rodgers et 
al., 2016). Furthermore, there are often significant difficulties in disentangling anxiety from 
ASD symptoms (Lecavalier et al., 2014). For instance, worries about change may be part of 
generalized worry or a feature of restricted, repetitive behaviors (Kerns & Kendall, 2012). 
Nevertheless, a small number of factor analytic studies have been able to distinguish anxiety 
from ASD (i.e., White et al., 2012; Renno & Wood, 2013), suggesting that these can likely be 
disentangled both statistically and clinically (see also Kerns et al., 2016).  
  Children with ASD also vary considerably in their intellectual and verbal abilities, 
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insight, emotional understanding and expression, and physiological symptoms (Cook et al., 
2013; Didehbani et al., 2012; Mazefsky et al., 2011; Ozsivadjian et al., 2012), which can 
impact their ability to rate or describe their emotional states (Grondhuis & Aman, 2012; 
Lecavalier et al., 2014). This often necessitates obtaining multi-informant reports from 
caregivers or significant others. Although anxiety rating agreement between caregivers and 
children with ASD has ranged from poor (i.e. Kaat & Lecavalier, 2015; Kerns et al., 2015; 
Renno & Wood, 2013) to moderately good (i.e. Magiati et al., 2014; Blakeley-Smith et al., 
2012; Ozsivadjian et al., 2014; van Steensel et al., 2012), Storch et al. (2012) found that 
parental reports contributed significantly to the clinical diagnosis of anxiety. Thus, parent 
report remains an important way of assessing anxiety in youth with ASD. 
 Another current consideration is whether adapted or modified anxiety measures are 
required, or whether existing measures developed for typically developing children have 
adequate reliability and validity for youth with ASD (Kerns & Kendall, 2012; Ollendick & 
White, 2012). There is, to date, no anxiety-specific informant measure developed specifically 
for ASD1, with the exception of the Anxiety Scale for Children – Autism Spectrum Disorder 
(ASC-ASD; Rodgers et al., 2016) which showed promising psychometric properties. A small, 
but growing, number of studies have examined the psychometric properties of existing 
caregiver-reported anxiety measures when used with 7-18 year old individuals with ASD and 
                                                 
1
 A small number of measures of broader psychopathology, including but not specifically focusing on anxiety, 
have been developed and tested in people with ASD. A modified structured caregiver interview piloted with 
children with ASD (Autism Comorbidity Interview-Present and Lifetime; ACI-PL; Leyfer et al., 2006) is 
currently not available for researchers or clinicians to use. The ASD-Comorbid for Children (Matson & Wilkins, 
2008) and the Baby and Infant Scale for children with Autistic Traits (BISCUIT; Matson et al., 2009) are 
informant rating scales with evidence of satisfactory psychometric properties, but which assess only a small 
number of anxiety symptoms as part of mixed worry/ depressed or anxiety/ repetitive behaviour subscales or 
which have a very limited age range. 
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verbal or cognitive functioning standard scores above  60 (see Table 1 for summary of 
caregiver reported measures; see also reviews by Lecavalier et al., 2014 and Wigham & 
McConachie, 2014). The parent measures examined tended to have satisfactory to excellent 
internal consistencies, and superior convergent and divergent validity than child self-reports. 
Few studies have examined alternative clinical cut-offs or have identified a consistent anxiety 
factor structure in ASD (see Table 1; White et al., 2015). 
The present study: rationale and research aims/ questions 
 Despite the recent availability of a promising anxiety specific measure based on 
ASD-relevant anxiety factors (Rodgers et al., 2016), there is still a need to further examine 
the factor structure of “typical” anxiety in ASD (White et al., 2015) and to identify a 
psychometrically sound measure to assess traditional DSM-derived anxiety symptoms in 
ASD in order to elucidate the common anxiety features across different populations.  
The present study therefore examined the psychometric properties and factor structure 
of the Spence Children’s Anxiety Scale-Parent version (SCAS-P). The SCAS-P provides a 
total, as well as six DSM-oriented subscale, scores and covers a wide range of anxiety 
symptoms, including a number of common specific phobia (the most commonly reported 
anxiety disorder in ASD; van Steensel et al., 2011) and social anxiety items assessing fear of 
negative evaluation (which may help in distinguishing caregiver-reported social avoidance 
due to fear of negative evaluation or due to ASD-related social communication challenges). It 
was selected in this study as it (a) has strong psychometric properties with typically 
developing children from diverse backgrounds (i.e. Spence, 1999; Nauta et al., 2004; 
Whiteside & Brown, 2008; Wang et al., 2015; Arendt et al., 2014); (b) is designed to parallel 
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DSM anxiety disorders’ criteria (albeit DSM-IV-TR criteria, as it was developed before the 
release of DSM-5 in 2013); (c) it is one of the most frequently used anxiety measures in ASD 
research (Grondhuis & Aman, 2012; Wigham & McConachie, 2014) and (d) it is a freely 
available informant measure officially translated in more than 20 languages, making it cost-
effective and easily accessible internationally in resource-limited clinical and research 
settings.  
In terms of its measurement properties, Zainal and colleagues (2014) reported 
that the SCAS-P full scale and subscales had acceptable to good internal consistency 
(α= .60 to .88), and satisfactory sensitivity (.75) and specificity (.71) against the K-
SADS clinical interview using a cut-off score of one standard deviation above the 
SCAS-P normative mean (Nauta et al., 2004) in a preliminary study of 32 youth with 
ASD. It has shown good preliminary evidence of moderate to good parent-child 
agreement (ICC= .59 to .69; Magiati et al., 2014; Ozsivadjian et al., 2014), although 
May and colleagues (2015) found poor parent-child agreement in a younger sample of 
cognitively able children with ASD. To our knowledge, no study has yet examined 
the measurement properties of the SCAS-P for use in children with ASD with a 
sufficiently large sample, nor has its factor structure been explored in ASD. The 
present study therefore aimed to investigate the psychometric properties (internal 
consistency, convergent, divergent and discriminant validity) and factor structure of 
the SCAS-P in a large, international, multi-site pooled sample of children with ASD.  
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Methods 
Participants 
Data were pooled from 12 different studies from the UK (N=9 studies; 465 
participants), Singapore (N=1 study; 241 participants) and the USA (N=2 studies; 164 
participants; see Table 2 for participant characteristics and details of original studies).  
Caregivers of 870 children (763 males, 87.7%) aged 5.58- 18.67 years old (M = 11.6, 
SD = 2.77) participated. Most of the informants were mothers (75%; Table 2). All 870 
participants had a professional clinical diagnosis of Autism or ASD (727; 83.7%), Asperger’s 
(111; 12.8%) or Pervasive Developmental Disorder-Not Otherwise Specified (32; 3.7%).  In 
all three countries, community professional diagnoses were based on national guidelines for 
ASD diagnosis involving the use of DSM-IV-TR or ICD-10 diagnostic criteria and a number 
of validated diagnostic assessments, including semi-structured caregiver interviews and child 
observations by qualified professionals (see Table 2). In addition, a number of studies also 
included a measure of autism symptom severity (n=479 participants; 55%; see Measures), of 
which 393 / 82.3% scored above clinical cut off on the respective caregiver-reported ASD 
measure or the clinician-rated Autism Diagnostic Observation Schedule (ADOS; Lord et al., 
20012). 
                                                 
2 130 of 130 (100%) met SRS cut-off (Constantino & Gruber, 2005) in studies 6, 11 and 12; 102 of 122 
(83.6%) met SCQ cut-off (Rutter et al.,, 2003) in studies 1, 9 and 10; 162 of 238 (68.1%) met the DBC-ASA 
cut-off of 14 in Study 7 (Steinhausen & Metzke, 2004); and 118 of 124 (95.2%) met ADOS autism-spectrum 
cut-off (Lord et al., 2001) in studies 3, 4, 11 and 12.  
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Twenty-one participants (2.4%) from Study 3, who had a caregiver-reported co-
occurring clinical diagnosis of anxiety disorder and who participated in Study 3 because they 
were seeking treatment for anxiety related concerns, constituted the clinical subsample in the 
present pooled database. All other participants were the “unselected” community sample, 
recruited from non-help seeking for anxiety settings (i.e. national or local autism research 
databases, special or mainstream schools, parent support groups, clinics where referral was 
for ASD but not for anxiety, etc.).  
Measures 
Anxiety. The Spence Children’s Anxiety Scale-Parent Version (SCAS-P; Spence, 
1999; Nauta et al., 2004)  is a caregiver-completed DSM-IV-TR derived anxiety measure 
comprising 38 items rated on a 4-point scale (from 0 to 3; higher scores=more anxiety) 
assessing symptoms in six subscales: separation (6 items; score range 0-18), social (6 items; 
0-18), generalized (6 items; 0-18), panic/agoraphobia (9 items; 0-27), physical injury/ 
specific phobias (5 items; 0-15) and obsessive compulsive disorder (6 items; 0-18). A SCAS-
P total score (range 0-114) one SD or more above the normative mean (mean 14.2; SD=9.7 in 
Nauta et al., 2004) is considered to be clinically elevated (Spence, personal communication, 
October 2012). In typically developing children, the SCAS-P has a factor invariance of six 
factors across age, gender and different countries, excellent convergent and divergent 
validity, acceptable to excellent internal consistency, and good discriminant validity between 
anxiety disordered and non-clinically anxious groups (Nauta et al., 2004; Whiteside & 
Brown, 2008; Li et al., 2011; Zhao et al., 2012). It also appears to have promising 
psychometric properties in youth with ASD in studies in the UK, Singapore and Australia 
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(Zainal et al., 2014; Magiati et al., 2014; Magiati et al., 2016; Ozsivadjian et al., 2014; 
Russell & Sofronoff, 2005).  
Autism Symptom Severity. The caregiver or teacher-reported Social Responsiveness 
Scale (SRS; Constantino & Gruber, 2005; n=130), the 29-item Developmental Behavior 
Checklist (Einfeld & Tonge, 2002) Autism Screening Algorithm score (DBC-ASA; n=238)3, 
the Social Communication Questionnaire (SCQ; Rutter et al., 2003; n=122) or the Autism 
Diagnostic Observation Schedule (ADOS; Lord et al., 2001; n=124) were used to establish 
the number of participants scoring above cut-off scores as a way to confirm caregiver 
reported clinical diagnosis of ASD and to measure autism symptom severity in some of the 
studies (see Table 2). 
IQ/ Adaptive Functioning. The Wechsler Intelligence Scale for Children–Third 
Edition (WISC-III; Wechsler, 1991; n=20), the Wechsler Abbreviated Scale of Intelligence 
(WASI; Wechsler, 1999; n=161), the Stanford Binet Intelligence Scales–Fifth Edition (SB5; 
Roid, 2003; n=54), the Kaufman Brief Intelligence Test–Second Edition (KBIT-2; Kaufman 
& Kaufman, 2005; n=43) or the Scales of Independent Behavior–Revised Short Form (SIB-R 
Short; Bruininks et al., 1996; n=239) were used as a measure of overall IQ or adaptive 
functioning in in some of the studies (see Table 2).  All these measures have a normative 
mean of 100 and a standard deviation of 15.  
Procedure 
                                                 
3
 The Developmental Behavior Checklist (Einfeld & Tonge, 2002) Autism Screening Algorithm score (DBC-
ASA) has been found to discriminate well between children with disabilities with and without ASD (Brereton et 
al., 2002; Steinhausen & Metzke, 2004). 
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 All studies were approved by their respective institutional ethics committees. The 
caregivers and youth were recruited according to the studies’ approved research protocols 
and completed the measures summarized above and in Table 2.   
Statistical Analytical Plan 
Missing data. No participant was excluded, and there was no more than 10% missing 
data for any one particular measure (Bennett, 2001). All missing data were managed and 
replaced according to manual/ measure guidelines4.  
Data Harmonization. Although pulling data together has many advantages in terms 
of increasing power, allowing the creation of larger and likely more representative of the 
population samples and maximizing the use of smaller-scale data (Griffith et al., 2015; 
Hussong et al., 2014), integration of data from different studies often employing different 
measures is also very challenging. Careful consideration therefore needs to be given to how 
the datasets can be harmonized as much as possible. Integrating data from intellectual, 
adaptive and autism symptom severity measures was complex, as different measures and 
informants were employed. To address this, and following methods discussed by Griffith and 
colleagues (2015), Hussong et al., (2013) and Schaap et al. (2011), we harmonized cognitive 
and adaptive functioning data, all of which had the same normative mean of 100 and SD of 
15 by creating an ordinal “approximate level of functioning” classification variable with 
scores ranging from 1 (=standard score <40 corresponding to severe/ profound ID range as 
per DSM) to 8 (SS ≥120, corresponding to superior functioning as per the Wechsler scales’ 
                                                 
4
 Average caregivers’ ratings were used to tabulate the subscale and total scores for eight participants in Study 7 
for whom SCAS-P data were given by both caregivers. 
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classification)5. To ensure higher levels of consistency, we harmonized only caregiver-
reported autism symptom severity measures6 by converting the raw scores from the different 
autism screening measures to a 0 to 1 metric (dividing the total raw score of each participant 
by each scale’s maximum score).  
 Statistical Analyses. To examine their fit in our ASD sample, a series of SCAS-P 
factor models identified in the literature (see Results) were constructed in CFA models within 
a general structural equation model framework with a robust maximum likelihood (MLR) 
estimator in MPLUS v5 (Muthén & Muthén, 2012) to generate model fit indices. The MLR 
estimator was used due to non-normally distributed data. The Satorra-Bentler Scaled Chi-
Square test was used to compare models to account for the scaling due to the use of the 
robust estimator. As the Chi-Square statistic tends to underestimate goodness of fit in large 
sample sizes (Bollen, 1989), Hu and Bentler (1999) recommend examining multiple indices 
RMSEA ≤.06; CFI ≥.95; and TLI≥.95 to determine the model fit. 
 Participants (n=8497) were then randomly assigned into two groups (n1= 425; n2= 
424) with similar rates of participants from the three countries. Each group was deemed 
                                                 
5
 8= Standard Score ≥120 (superior); 7= 110-119 (high average); 6= 90-109 (average); 5= 80-89 (low average); 
4= 70-79 (borderline); 3= 55-69 (mild ID range); 2= 40-54 (moderate ID range); and 1= < 40 (severe or 
profound ID range); categories based on the Wechsler scales classification and DSM-5 ID ranges. All cognitive 
and adaptive measures employed in the different studies correlate very highly with each other in data presented 
in their respective manuals. We acknowledge that different measures assess different components of intellectual/ 
adaptive functioning and similar, but also different, underlying constructs, which is why we did not use the 
actual scores, but rather the broader classification categories. This approach maximizes use of all available data, 
while still acknowledging that the scores obtained are highly correlated, but not directly comparable – this is the 
reason we did not use the continuous standard scores.  
6 In Study 12, 43 participants had ADOS, SRS, and SCQ data; the SRS scores were used for these participants, 
because its scoring method provides greater score range. 
7
 The clinical subsample of 21 participants from Study 3 were not included in these analyses, as they had a 
known identified anxiety disorder and were recruited into the research study due to specifically seeking 
intervention for anxiety related difficulties.  
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sufficiently large to explore the underlying factor structure using Principal Component 
Analysis (PCA) and validating the identified factor structure using CFA (Norris & Lecavalier 
2010; Tabachnick & Fidell, 2013; Yong & Pearce, 2013). The two subgroups were not 
significantly different in terms of chronological age, gender, ASD symptomatology, 
functioning, and SCAS-P anxiety total score (p>.05; all were small effect size differences, 
except harmonized functioning which was small-to-medium). The PCA (with direct oblimin 
rotation, as the factors were theoretically and empirically correlated; Spence, 1998) was run 
with the first group. Parallel analysis and scree plots determined the number of factors. The 
PCA derived model was then tested for model fit in the second subsample.  
 The reliability and validity of the existing SCAS-P and PCA-derived SCAS-P was 
examined in the full sample. Pearson’s, biserial, Spearman’s Rho and Cramer’s V 
correlations examined the relationship between SCAS-P total and subscale scores with 
demographic variables, harmonized autism symptomatology, and functioning classification. 
Welch ANOVAs with Bonferroni corrections, Chi square tests, and Games–Howell Post-Hoc 
tests were used to examine differences (i) among the three countries; (ii) between those who 
met ASD cut-off in the screening measures (n=394) and those who had professional 
diagnoses of ASD but did not meet ASD cut-off or did not have measures of autism 
symptomatology completed (n=476); and (iii) between community (n=849) and clinically 
referred for anxiety (n=21) participants. Effect sizes were interpreted as per Cohen (1988; 
e.g. r<.30 small; .30-.49 medium; >.50 large; d <.49 small; .50-.79 medium; large >.80).  
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Results 
Preliminary analyses: differences between samples/ countries and between subsamples 
with and without ASD screening data 
Excluding the clinically referred for anxiety subsample from Study 3 (n=21), the three 
country subsamples differed statistically significantly in chronological age, SCAS-P total 
score, ASD symptomatology, functioning classification, and gender rates with small to large 
effect size differences (Table 3). Post-hoc Games–Howell tests showed that the UK 
subsample had higher SCAS-P total score and ASD symptomatology compared to the US and 
Singaporean participants with medium-to-large effect size differences. The UK and US 
participants were also significantly older and higher functioning than those from Singapore 
with a small and large effect size difference respectively (Table 3). However, the country 
differences in SCAS-P total scores were no longer significant after controlling for age, 
gender, functioning, and ASD symptomatology (F(2, 355)=1.91, p=.15, d=.049). 
Also excluding the clinically referred subsample, there were statistically significant 
differences in chronological age, SCAS-P (total, social and generalized anxiety scores only), 
mean functioning classification, and gender between the participants with professional 
diagnoses of ASD who scored above clinical cut-off in one of the different screening 
measures employed in the pooled studies (n=376) and the subsample with professional 
diagnoses who scored below recommended clinical cut-offs in the screening measures 
administered or who had no ASD symptom ratings available (n=473), but effect sizes of these 
differences were mostly small (p<.05, .007 ≤ effect sizes ≤ .19; Table 4), with the exception 
of functioning classification, where the participants not meeting cut-off or not having ASD 
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screening data available had somewhat higher functioning rankings (Table 4). The difference 
in SCAS-P anxiety total score between the two subsamples remained significant when age, 
gender, and functioning classification were controlled for, but the effect size of the difference 
was very small (Table 4). Because of the small effect size differences between those with and 
without ASD screening measure data, and as all studies had recruited participants with valid 
professional diagnoses following established national procedures, we proceeded with full 
sample analyses. 
Comparison with SCAS-P norms 
 The pooled unselected subsample had significantly higher mean SCAS-P total and 
subscale scores than published norms (p<.001; Nauta et al., 2004; Table 5). Using the 
suggested cut-off score of >24, 76.2% (16/ 21) participants in the clinical subsample as 
compared to 46.8% (397/ 849) from the unselected subsample scored above cut-off.   
Item analyses  
 All the items had at least .33 corrected item-total correlations, except item 16 (“my 
child needs to keep checking that s/he has done things right”; r=.13). The average corrected 
item-total correlation for the 38 SCAS-P items was .52 (SD=.11). The average corrected 
item-subscale correlation was .53 (SD=.11) and the average corrected subscale-total 
correlation was .69 (SD=.10).  
Internal Consistency 
Internal consistency for the total score items was excellent at α=.93. For the subscales, 
all Cronbach's alphas were >.75, except physical injury which was suboptimal (Table 5).  
Validity  
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Convergent validity. The SCAS-P total and subscale scores had moderate to strong 
positive correlations with the DBC-anxiety subscale (r (236) =.64 for total; r (236) =.32-.56 
for subscales; all p<.001; n =238 from Study 7 only in which used the DBC). 
Divergent validity. SCAS-P had non-significant or small correlations (<.20) with 
age, gender, and overall functioning classification, with the exception of a positive small-to-
medium effect size relationship between age, functioning classification and social phobia, 
and between overall functioning and social and generalized anxiety (Table 6). ASD 
symptomatology had significant medium-to-large positive correlations with SCAS-P total 
and subscale scales, except for the physical injury subscale which had a small correlation 
(Table 6). Using data from Study 7 only, the SCAS-P had small-to-moderate correlations 
with the DBC-disruptive/antisocial subscale (r (236) =.47 for total; r (236) =.23-.44 for 
subscales; all p<.001).  
Discriminant validity. The clinical subsample from Study 3 (n=21) had 
significantly higher SCAS-P total scores, generalized and social anxiety scores than 
the unselected subsample (Table 7).  
Confirmatory Factor analysis 
 Four different factor models examined by Nauta et al. (2004) in the normative SCAS-
P sample were explored (Table 8). The one factor model provided a better fit for the data than 
the null model, but the six uncorrelated factor model did not improve the model fit. The six 
correlated factor model provided a better fit than six uncorrelated factors. Lastly, the 5-factor 
model with Generalized Anxiety as a second-order factor provided a significantly better fit 
than the previous models. Overall, however, the indices suggested that none of these models 
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provided adequate fit for our ASD sample. A PCA was thus conducted to explore the SCAS-
P factor structure in our sample8.     
Revised Factor Structure Analyses 
Principal Component Analysis.  PCA was first run on the 38 SCAS-P items with the 
randomly selected first half of the sample’s participants (n1=425), with direct oblimin 
(delta=0) rotation. The Kaiser-Meyer-Olkin test of sampling adequacy was excellent at .93 
(Field, 2009). Bartlett’s test of sphericity was also significant (χ2 (703, n=425) = 7891.76, p < 
.001) indicating that the inter-item correlations were adequate for PCA. The points of 
inflexion on the Scree plot suggested one, three, or five components (Figure 1), while eight 
factors had eigenvalues >1. Parallel analysis (O'Connor, 2000) suggested five components.  
Extracting for five components and suppressing correlation coefficients <.38 to ensure 
that the selected items had minimal relation with the component, the initial five components 
accounted for 51.1% of the variance. As several items had communalities significantly below 
.40 (Costello & Osborne, 2005) or factor loadings below .38, they were removed sequentially 
and the PCA was re-run each time until a simple structure was achieved (Thurstone, 1947). 
Items 16, 23, 29, and 34 were removed sequentially because of low communality, followed 
by items 3 and 36 because of low factor loadings <.38, and lastly items 17 and 38 due to 
cross-loading. A simple factor structure of five components was obtained with the remaining 
30 items (see Table 9) accounting for a total of 57.9% of the variance9.  
                                                 
8 We also ran the CFA with the participants scoring above cut-off in the autism screening measures only and the 
results were consistent with the CFA for the full sample, therefore we report the full sample analyses.  
9
 We first ran the PCA following the same steps and criteria only with the participants who scored above cut-off 
in one of the three caregiver-reported screening measures employed in the different studies and found the same 
5-factor structure explaining very similar variance (54.8%), the only difference being that two more SCAS-P 
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The five components had significant positive moderate-to-high inter-correlations (r 
≥.38). The first component, Social/Generalized Anxiety symptoms, accounted for 35.2% of 
the variance and its nine items were mainly on social anxiety, but with some generalized and 
separation anxiety symptoms. The second component accounted for 7.3% of the variance and 
contained 5 items, measuring mostly separation anxiety symptoms but also fear of darkness 
and feeling scared. The third component contained eight items measuring somatic or panic 
symptoms accounting for 6.5% of the variance. The fourth factor contained four items all 
assessing obsessive-compulsive symptoms and accounted for an additional 4.7% of variance. 
The last component was a Specific Phobia factor containing four items on medical/dental 
phobia and fear of public places or using public transport and accounting for 4.2% of the 
variance.  
Item analyses and reliability of revised PCA-derived SCAS-P. The item means 
and SDs, corrected item-total, corrected item-subscales and corrected subscale-total 
correlations of the revised 30-item SCAS-P are presented in Table 5. All items had at least 
.34 corrected item-total correlations. The average corrected item-total correlation, item-
subscale correlation and subscale-total correlations were .54 (SD=0.09), .59 (SD=0.08) and 
.62 (SD=0.06) respectively. Internal consistency for the 30-SCAS-P items was .93 and α≥.69 
for the subscales (Table 5).  
Validity of the PCA-derived SCAS-P. The PCA-derived SCAS-P total and its 
subscales had good convergent validity with the DBC-anxiety subscale in Study 7 (r (236) 
                                                 
items were included in the final solution. Given the consistent findings, we report on the analyses for the full 
sample, as the strength of this pooled database lies primarily in the large, diverse sample. 
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=.65 for total; .38-.55 for subscales; all p<.001). In the same study subsample, the revised 
SCAS-P total and subscale scores were positively correlated with the DBC-
disruptive/antisocial subscale (r (236) =.26-.46, p<.001) with small to medium effect size 
correlations. In the full sample, the PCA-derived SCAS-P total and subscales scores had non-
significant or significant small correlations with age, gender and functioning classification, 
indicating divergent validity (with the exception of small-to-medium effect size correlations 
between mixed generalized/social anxiety subscale and age, functioning classification, and 
ASD symptomatology; Table 6). The SCAS-P total and the mixed generalized/ social anxiety 
subscale scores were significantly higher in the clinical subsample than the unselected 
participants, providing some preliminary evidence of discriminant validity, although effect 
sizes were small (Table 7). The original SCAS-P full-scale correlated r (868) =.99 with the 
PCA-revised SCAS-P full scale. The original SCAS-P subscales were also positively and 
highly correlated with their corresponding revised subscales (i.e., r=.88-.95), except for the 
PCA-derived Physical Injury/ Specific Phobia subscale which was moderately correlated 
with the original SCAS-P Physical Injury subscale (r (868)=.57).  
Confirmatory Factor Analysis. A CFA was then run in the other half of the pooled 
sample (n2=424) to test the goodness of fit of the PCA derived model summarized above (and 
in Table 8). The model fit indices (CFI, TFI, RMSEA) suggested that the PCA derived model 
did not fit the other half of our sample adequately (Table 8). 
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Discussion 
Measurement properties of the original 38-item SCAS-P 
Overall, the original SCAS-P full scale and all but one subscales had excellent 
internal consistencies and convergent, divergent and discriminant validity similar to or better 
than SCAS-P data reported in typically developing (TD) children (Whiteside & Brown, 2008; 
Li et al., 2011; Nauta et al., 2004). The Physical Injury subscale had a low Cronbach’s alpha 
of .55, consistent with previous findings (Li et al., 2011; Magiati et al., 2016; Nauta et al., 
2004) suggesting that this particular subscale, although commonly endorsed in our sample, 
may be inconsistent psychometrically. 
However, the SCAS-P total correlated .47 with the DBC antisocial/ aggressive 
subscale, suggesting some overlap between anxiety and externalizing behaviors in our 
sample. This is consistent with other qualitative and quantitative studies reporting that often 
anxiety in ASD may come across or be expressed as irritability or aggression (Ozsivadjian et 
al., 2012; Mazefsky et al., 2012; Lydon et al., 2015). The positive association of age and 
functioning with the SCAS-P social anxiety subscale is developmentally expected - 
increasing social anxiety symptoms are often observed with age in typically developing 
children, while studies in ASD have also shown that with increases in age and ability comes 
increased awareness of social isolation and difference, a risk factor for developing anxieties 
about social situations (i.e. Kerns et al., 2016; Sukhodolsky et al., 2008). At the same time, 
the original SCAS-P performed less well in the present study in terms of structural and 
discriminant validity as compared to other published studies with typically developing 
children (Nauta et al., 2004; Whiteside & Brown, 2008).  
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Factor structure of the original SCAS-P in ASD 
 The SCAS-P factor models in the existing literature (see Nauta et al., 2004) did not 
provide an adequate fit for our data, suggesting that the underlying conceptual and structural 
basis of the SCAS-P anxiety symptoms may to some extent be different in ASD. Other 
studies exploring factor structures of existing anxiety measures in ASD have also reported 
similarly poor fits -  Renno & Wood (2013) and White et al. (2015) using the 
Multidimensional Anxiety Scale for Children-Parent version (MASC-P; March et al., 1997); 
and Stern et al. (2014) using the Screen for Child Anxiety Related Disorders (SCARED-P; 
Birmaher et al., 1997). White et al. (2015) found a mixed factor of separation anxiety and 
panic items and two separate social anxiety factors (i.e., evaluation and performance focused) 
using the MASC-P, while Stern et al. (2014) observed a mixed panic and generalized anxiety 
factor comprising a mixture of items from the other subscales, such as school phobia, using 
the SCARED-41-P. It is possible that the lack of fit of the factor structures of existing 
measures in different samples of participants with ASD may be explained by the fact that 
anxiety symptoms in ASD may be manifestations of broader and more complex underlying 
pathways and processes, such as emotional dysregulation, alexithymia, hyper-arousal, 
intolerance of uncertainty and/ or sensory sensitivities (e.g. Kerns et al., 2016; White et al., 
2014; Mazefsky et al., 2012; South & Rodgers, 2017). These broader underlying ASD-related 
vulnerabilities may also explain the findings of “mixed” factors in the earlier and the present 
studies in ASD. Others, however, have reported preliminary evidence of a good fit (i.e., 
Hallett et al., 2013a, using the CASI-Anxiety). Of the “traditional” anxiety factors, separation 
and social anxiety subscales, and panic subscale (physiological symptoms), to a lesser extent, 
were most consistently replicated in the studies mentioned earlier.  
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Measurement properties of the revised PCA-derived 30-item SCAS-P  
The PCA suggested an alternative five-factor SCAS-P structure, with a number of 
items loading on factors not commonly suggested in the existing literature (Nauta et al., 
2004). For example, social and generalized anxiety items loaded together on one “mixed” 
factor. As discussed earlier, it is possible that, compared to normative samples, some 
individual SCAS-P items load onto different anxiety factors because of different, and ASD-
distinct, underlying pathways explaining these fears and anxieties (White et al., 2015; Kerns 
et al., 2016; South & Rodgers, 2017). For example, two items relating to fears of using public 
toilets or being in crowds load onto the social anxiety and panic/ agoraphobia factors 
respectively in the normative SCAS-P. However, these items load onto the specific phobias 
factor in the PCA-derived SCAS-P in this study, which could be because these fears may be 
related to specific overwhelming sensory experiences in toilets and crowds for those with 
ASD, rather than to “traditional” social anxiety concerns (see Kerns, 2016 for more on the 
clinical implications of this in the differential diagnosis of anxiety in ASD).  
Compared to the original SCAS-P, the revised PCA-derived SCAS-P had similar 
corrected internal consistencies (with the exception of the specific phobia subscale, which 
was better in the PCA-derived SCAS-P factor structure), item-total, item–subscale, and 
subscale-total correlations, divergent validity and discriminant validity, but somewhat 
stronger convergent validity, as shown by higher correlations with the DBC anxiety subscale. 
ASD symptomatology was less strongly associated with the PCA-derived SCAS-P subscales, 
with the exception of a medium association with mixed GAD/ social subscale. This could 
potentially mean that PCA helped remove overlapping items that tap on both anxiety and 
ASD severity.  
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The moderate similarities in content and the high positive correlations between the 
original SCAS-P and the corresponding revised subscales suggest that the underlying anxiety 
factors may generally be similar. Nevertheless, the lack of a consistent, replicable, and 
adequate factor structure in the two randomly selected large subsamples in the present pooled 
dataset is difficult to interpret. Clearly, differences in recruitment and sample characteristics 
may partially explain the lack of consistency, as we were able to compare the two randomly 
selected subsamples on only some characteristics and measures. The large heterogeneity of 
ASD may contribute to less consistent structures, or possibly to different underlying 
structures for different subgroups. Furthermore, the items to which the caregivers responded 
were all enquiring about typical anxiety presentations and there was no further clarification or 
elaborations requested (i.e. whether what parents were describing related specifically to 
anxiety anticipation or to ASD symptoms and associated distress more broadly; (see Kerns, 
2016). It is possible that measures which will include both “traditional” as well as more 
ASD-distinct anxiety presentations and symptoms may derive more comprehensive, and thus 
more consistent, structures across different samples. Currently, however, due to the concerns 
with lack of consistency, it is likely premature to use the PCA-derived SCAS-P scale and 
factor structure for clinical or research purposes.  
Comparing the measurement properties of the original/ revised SCAS-P to other 
existing anxiety measures in ASD 
Both the original and revised SCAS-P versions and the SCARED-71-P have 
demonstrated promising evidence of discriminant validity in terms of significantly higher 
means in the clinical help-seeking for anxiety sample compared to the unselected 
community-recruited sample, although this needs to be confirmed with studies employing 
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clinical diagnostic interviews to establish sensitivity and specificity of the measure. Good 
sensitivity and specificity for the SCARED-41-P and SCARED-71-P has been reported in a 
clinically anxious help-seeking sample (Van Steensel et al., 2013), but much poorer accuracy 
was reported for a number of other parent and self-report anxiety measures developed for 
typically developing children when compared against the augmented for ASD Anxiety 
Disorder Interview Schedule Child/ Parent (ADIS C/P; Kerns et al. 2015; Stern et al., 2014; 
van Steensel et al., 2012).  
Both original and revised PCA-derived SCAS-P versions and the other anxiety 
measures examined in the literature so far had poor structural validity, except for the CASI-
Anxiety which showed promising evidence of adequate model fit (Hallett et al., 2013a; 
Renno & Wood, 2013; Stern et al., 2014; White et al., 2015). Overall, with regards to existing 
anxiety measures, both the original SCAS-P and the SCARED-71-P and CASI-Anxiety 
appear to be promising in their use with children and adolescents with ASD, but future 
research needs to examine how to improve their structural validity, sensitivity and specificity 
for use as a screening tool with this population. It is likely that such improvements in the 
structural validity will come from including and piloting in existing measures addendum 
subscales measuring more ASD-specific anxiety presentations (i.e., see Kerns et al., 2017; 
Bearss et al., 2015; Rodgers et al., 2016). 
Strengths and Limitations of the present study 
This large pooled ASD sample which includes participants from 12 studies from three 
countries made it possible to examine structural validity and factor structure of, as well as to 
test the adequacy of the new structure in, a large diverse group of young people with ASD. 
As most of the participants were recruited through community settings, this allowed the 
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investigation of the use of the SCAS-P in non-clinically referred young people for anxiety 
with ASD.  
At the same time, however, pooling participants from multiple studies and countries 
also presented several challenges and harmonization of data from different sources and 
measures is inherently difficult as there was no common measure for ASD severity, cognitive 
or adaptive functioning. Some loss in the richness and range of data available for 
harmonization is inevitable (in the present study, this was the case for scores from 
intellectual/ adaptive functioning and autism symptomatology which were pooled together in 
ordinal categories, rather than used continuously). It is also possible that pooling data from 
12 studies in three countries might have masked other potential differences, such as 
sociocultural differences, beyond the identified examined differences in age, gender, overall 
functioning, or ASD symptom severity. Furthermore, only some of the pooled studies had 
additional child report anxiety measures or clinician diagnostic interviews available, thus we 
were not able to investigate informant agreement nor to establish which participants met 
clinician-rated diagnostic criteria for an anxiety disorder. Lastly, although participants across 
all levels of intellectual/ verbal/ adaptive functioning were included, our pooled sample 
comprised more children and adolescents with ASD who were functioning within the non-
impaired range in terms of cognitive/ adaptive skills.  
Possible implications  
For Clinical Practice. Following further replication, the SCAS-P appears to be a 
reasonably good choice as a freely available first line screening tool for typical DSM-derived 
anxiety in ASD, provided that it is employed alongside other multi-informant and multi-
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method information gathering approaches (i.e. using the ASC-ASD by Rodgers et al., 2016 to 
also examine more ASD-related anxiety difficulties; or the ADIS C/P ASD addendum 
clinical interview by Kerns and colleagues, 2014; see also Vasa et al., 2016). If the original 
SCAS-P is used, we recommend the use of the total score as a general screen for anxiety, and 
not of the separate subscales, as the underlying subscale/ factor structure remains inconsistent 
and unclear and requires further exploration. We specifically caution against the use of the 
original SCAS-P Physical Injury subscale, as some of its items may not be tapping on a latent 
specific phobia factor. Furthermore, clinicians should not simply invite caregivers to “tick” 
symptoms off the checklist; instead, we encourage them to explore the informants’ responses 
further, in order to establish the precise content of anxiety concerns and to elucidate whether 
they may be best explained or understood as anxiety involving anticipation or as a distressed 
reaction as a consequence of their ASD symptoms (e.g., Kerns & Kendall, 2012; see Kerns et 
al., 2014; 2016 for evidence and recommendations differentiating ASD and anxiety 
symptomatology using systematic interviewing procedures).  
For Future Research.  Several unanswered questions remain. In our summary in 
Table 1, it appears that measures developed for typically developing youth generally do not 
have strong evidence for discriminant validity, sensitivity or specificity, or good factor 
structure fits when employed in youth with ASD. CFAs often reveal that the measures’ 
original structures have inadequate fits in ASD samples, although studies using EFAs have 
identified relatively similar factor structures consistently using different measures (i.e., 
Hallett et al., 2013a; Renno & Wood, 2013; Stern et al., 2014; White et al., 2015; this study).  
Future research should thus look into (i) modifying, adapting or enhancing existing 
measures for individuals with ASD, while gathering normative ASD data; and/ or (ii) 
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developing and improving ASD-specific anxiety measures (Kerns et al., 2015; Sterling et al., 
2015; White et al., 2015; Rodgers et al., 2016). Children’s cognitive profile and verbal skills 
also appear to affect anxiety symptom endorsement to some extent (Hallett et al., 2013b; 
Witwer & Lecavalier, 2007) and hence, it will be important to validate the measures, 
establish norms and cut-offs separately for ASD youths of different levels of ability.  
Furthermore, youth with ASD also present with more idiosyncratic ASD-related 
anxiety (see Bearss et al., 2015; Kerns et al., 2014; Ozsivadjian et al., 2012; for a review, see 
Magiati et al., 2017). Future research should examine how ASD-related anxiety symptoms 
relate to traditional DSM-derived anxiety symptoms in young people with ASD (Kerns et al., 
2014) and the underlying structural validity of measures including both traditional and ASD-
related anxiety symptoms. Researchers can use existing work with focus group 
methodologies which have generated candidate anxiety items to develop an ASD-specific 
anxiety measure (Bearss et al., 2015; Rodgers et al., 2016) or augment modified measures of 
traditional DSM-defined anxiety symptoms with an ASD-addendum subscale (Ozsivadjian et 
al., 2014; Kerns et al., 2014). 
Research efforts to better assess, understand and treat anxiety in children and 
adolescents with ASD have intensified and have considerably improved our understanding of 
anxiety in ASD. The present study contributes to this growing body of literature by 
examining a widely used and easily accessible caregiver-report anxiety measure. Future 
research efforts should focus on improving our understanding of the structure of, and 
relationship between, traditional and more ASD-related presentations of anxiety and our 
ability to reliably and validly identify these in individuals with ASD. 
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Table 1. Summary of measurement properties of caregiver-report anxiety measures in studies of young people with ASD 
Measure/informant Studies ASD Participants Reliability Validity 
 
1. Autism Spectrum 
Disorder – Comorbid for 
Children (ASD-CC): 
Worry/depressed 6-item 
subscale 
 
Matson & 
Wilkins 
(2008) 
Matson et al. 
(2009) 
 
 
 
113-177 2-17 year 
olds with ASD; 
clinical and 
community recruited  
 
Mixed functioning 
(some with ID,  
Down syndrome) 
α=.74 
 
Mean item inter-rater 
(familiar family member): 
α=.46 
 
Mean item test-retest of 2 
weeks: α=.55 
Structural: EFA identified one worry/depressed factor among other 
internalising and externalising symptoms 
Convergent: Large correlations (i.e. .52 to .68 with BASC-2 
somatization, depression, anxiety) 
Divergent: Zero to moderate correlations (i.e. .07 to .32 with BASC-
2 attentional problems, withdrawal, hyperactivity, aggression, 
conduct problems 
Rieske et al. 
(2013) 
 
53 2-16 year olds 
with ASD from 
clinical setting; some 
with ID 
 Convergent: Large correlations (i.e. .70 to .74 with BASC-2 
depression, anxiety, internalizing total) 
Divergent: non-significant or small correlations (i.e. -.05 to .14 with 
BASC-2 attentional problems, daily living) 
2. Child and Adolescent 
Symptom Inventory 
(CASI): Anxiety Scale 
 
 
Hallett et al. 
(2013a) 
 
415 4-17 year olds 
with ASD from 
clinical settings; 
subgroups of IQ ≥ 70 
and < 70  
Total items α=.87 
 
Subscales α=.65 to .85 
 
 
Structural: Promising evidence from EFA and CFA on 4-factor 
structure – GAD, SAD, Over-arousal, SoP 
Divergent: Small-to-moderate correlations (i.e. .08 to .31 with OCD 
measure, Vineland adaptive behaviour, Aberrant Behavior Checklist 
irritability, social withdrawal, stereotypy and inappropriate speech, 
PDD measure) 
White et al. 
(2012) 
 
30 12-17 year olds 
from clinical setting  
 
Verbal IQ≥70 
Total α=.85 
 
Inter-informant (caregiver/ 
child): r=.45 
Convergent: Large (.78 with MASC-P); .47 with depressive 
symptoms 
Divergent: Small non-significant correlations (-.20 to .15 with ADOS 
and Verbal IQ)  
3. Pediatric Anxiety Rating 
Scale 
 
Clinician-report 
Storch et al. 
(2012) 
 
72 7-17 year olds 
with ASD from 
clinical settings 
IQ &VIQ >70 
Total  α = .59 
Inter-rater r=.86 
Test-retest after 26 days 
r=.83 
Convergent: .40 to .62 with MASC-P, CBCL anxiety and 
internalizing symptoms,  clinician rated severity of anxiety 
Divergent: .03 to .47 with ADOS and CBCL externalizing 
behaviours subscales 
Kerns et al 
(2015) 
54 7-17 year olds 
unselected/ 
community sample; 
IQ> 60 
total  α = .90 
 
Convergent:.46 to .60 with SCARED-P and BASC-2 Parent 
Poor sensitivity (=.53) & strong specificity (=.95) using original cut-
off; stronger specificity (=.93), but weaker specificity (=.71) with 
alternative cut-off  
4. Revised Child Anxiety 
and Depression Scale 
(RCADS-P) 
Kaat & 
Lecavalier 
(2015) 
46 8-16 year  olds 
with ASD with > 
50% seeking 
treatment 
 
IQ≥ 55 
Total α = .91 
Subscales α = .57 to .88 
Test-retest after  2 to 3 
weeks: total = .82, 
subscales = .76 to .87 
Parent-child agreement: 
Total= .23; Subscales= .08 
to .27 
Convergent: Large correlations (i.e. .64 to .85 with MASC-P, CSI 
anxiety) 
Divergent: Non-significant correlations (i.e. -.20 to .29 with child 
variables, emotion recognition, ADOS, CSI externalizing behaviour 
subscales, but .69 with CSI depressive disorders) 
5. Multidimensional 
Anxiety Scale for 
Children-Parent 
Renno & 
Wood (2013) 
 
88 7-11 year olds 
with ASD and 
comorbid anxiety 
Total score α = .86 
Subscales α = .77 to .88 
 
Discriminant/Structural: Anxiety symptom severity can be 
distinguished from ASD symptom severity with CFA, but poor 
discrimination between separation and social anxiety 
(MASC-P) disorder 
IQ>70 
Parent-child agreement: 
Total= .17; Subscales= .06 
to .50 
Convergent: r=.18 to .58 with semi-structured interview ratings 
Divergent: Non-significant or moderate correlations (i.e. -.04 to .40 
with parent rated and semi-structured interview ASD symptom 
severity 
White et al. 
(2012) 
30 12-17 year olds 
with ASD and 
comorbid anxiety 
disorder; VIQ≥70 
Total: α = .90 
 
Parent-child agreement: 
Total=.36 
Subscales=.11 to .52 
Convergent: .78 with CASI 
Divergent: Non-significant or moderate correlations (-.26 to .385 
with ADOS, VIQ, depressive symptoms) 
Discriminant: Poor (i.e. not significantly higher than a published 
unselected ASD sample; only 23.3% met cut-off)  
White et al.  
(2015) 
465 7-17 year old 
with ASD and 
comorbid anxiety 
disorder;  
VIQ>70 
Parent-child agreement 
for Total =.38 
 
Inter-item subscale 
correlations: 
.33 to .34, except .18 for 
harm avoidance 
Structural: Poor model fit; EFA suggested alternative 4-factor 
structure (SAD/Panic, SoP evaluation focused, somatic symptoms, 
SoP performance focused) 
 
6. MASC-2 
 
Parent report (MASC-2-
P) 
Kaat & 
Lecavalier 
(2015) 
46 8-16 year olds 
with ASD;  >50% 
seeking treatment for 
anxiety;  
IQ≥ 56 
Total α = .92;  
Subscales α = .67 to .95 
Test-retest after  2 to 3 
weeks: Total=.83; 
subscales = .71 to .90 
Parent-child agreement: 
Total= .23; subscales= .0 
to .45 
Convergent: .33 to .85 with RCADS-P, CSI anxiety; .65 with CSI 
depressive disorders 
Divergent: Non-significant correlations (i.e. -.21 to .26 with child 
variables, emotion recognition, social cognition, ADOS, CSI 
externalizing behaviour subscales 
 
7. Screen for Children for 
Anxiety and Related 
Disorders (SCARED-
41-P) 
 
Blakeley-
Smith et al. 
(2012) 
 
Stern et al. 
(2014) 
129 7-18 year olds 
with ASD/ clinical 
sample; VIQ≥70 
Total score α= .90 
Subscales α=.73 to .89 
 
Parent-child agreement  
(in a sample of 63 8-14 
year olds with VIQ≥80): 
total= .52; subscales=.27 
to .71 
 
Structural: Items loaded on their original factors generally in PCA 
(Panic, SAD, SoP), except GAD and school phobia items  
 
Convergent: small-to-moderate correlations (i.e. total r=.44 with 
clinician global clinical severity rating; Subscales r=.28 to .46 with 
semi-structured interview ratings 
 
Good Sensitivity: total = .71, subscales = .70 to 1.00 
Acceptable Specificity: total = .67, subscales = .33 to .83 
Kerns et al. 
(2015) 
 
54 7-17 year olds 
with ASD; 
unselected, but 37% 
had another anxiety 
disorder;   
IQ>60 
Total score α=.91 
 
Parent-child agreement: 
Total =.33 
Convergent: Large correlations (i.e. total r= .60 to .73 with BASC2-P 
and PARS) 
 
Sensitivity (.58) and specificity (.86) with original cut-off; better 
sensitivity (.95), but poorer specificity (.62) with alternative cut-off 
8. SCARED-71-P 
 
 
Van Steensel 
et al. (2013) 
115 7-18 year olds 
with ASD & 
comorbid anxiety 
disorder 
 
High functioning 
Total score α = .94 to .95 
Subscales α = .70 to .88 
 
Parent-child agreement: 
Total score r=.39 to .41 
 
Convergent: .42 to .75 with semi-structured parent interview ratings 
or another SCARED-71 caregiver report 
Discriminant: Good (i.e. significant differences in subscales scores 
between disordered and no disorder, except for OCD subscale 
Sensitivity (total =.95; subscales = .78 to .90); Specificity 
(subscales= .39 to .67) with original cut-off 
Parent-child agreement on 
diagnosis of anxiety 
disorder: .52 to .85 
Better specificity (.67 to .71) but lower sensitivity (.71 to .80) with 
alternative cut-off for separation, social & generalized anxiety 
9. Spence’s Child Anxiety 
Scale-Parent (SCAS-P) 
Zainal et al. 
(2014) 
 
32 6-18 year olds 
with ASD 
unselected;  
NVIQ ≥70  
 
 
Total score α = .88 
Subscales α = .60 to .78 
 
 
Convergent: Moderate-to-large correlations (i.e. .48 to.61 with semi-
structured interview rating and DBC-Anxiety) 
Discriminant: Good (i.e. significant difference between anxiety 
disordered and no disorder groups on total score, social phobia 
subscale and panic subscale) 
Promising Sensitivity (.71), specificity (.76), NPV (.90), but poor 
PPV (.45) 
Magiati et al. 
(2014) 
38 8-18 year old 
unselected;  
NVIQ >70 
Total score α = .88 
Subscales α = .51 to .80 
Parent-child agreement: 
Total=.69; Subscales=.42 
to .78; Mean item=-.01 to 
.69 
 
Magiati et al. 
(2016) 
241 5-17 year olds 
with ASD;  
unselected sample;  
Mixed level of IQ 
and/or adaptive 
functioning (SIB-R 
SS=58.8 (40.4)) 
Total score α = .87 
Subscales α = .47 to .76 
 
Divergent: -.01 to .48 with age, gender, adaptive functioning and 
DBC autism symptom severity 
Ozsivadjian et 
al. (2014) 
30 10-16 year olds 
with ASD from 
special school;  
IQ≥70 
Total score α =.92 
Parent-child agreement: 
Total score =.59 
Divergent: non-significant correlation with full scale IQ, but small 
correlation with autism symptom severity (.38) 
May et al. 
(2015) 
44 8-13 year olds 
with ASD from 
clinical sample; 
IQ≥70 
Parent-child agreement: 
Total score =.25 
Subscales = .11 to .31 
 
 ID= Intellectual disability; EFA = Exploratory Factor Analysis; BASC= Behaviour Assessment System for Children; PDD= Pervasive Developmental disorder; ADOS=Autism Diagnostic 
Observation Schedule; CFA= confirmatory factor analysis; GAD= generalized anxiety disorder; SAD= Separation Anxiety Disorder; SoP= Social Phobia; IQ= Intelligence Quotient; 
VIQ=Verbal intelligence Quotient; PCA= principal component analysis; NVIQ = Non-verbal Intelligence Quotient; CBCL= Child Behavior Checklist; PPV= Positive Predictive Value, 
NPV=Negative Predictive Value; DBC= Developmental Behavior Checklist; ADIS=Anxiety Disorders Interview Schedule.  
 Table 2. Participant characteristics in current pooled database and for each dataset 
Study N  Sample description Recruitment & inclusion-
exclusion criteria 
Diagnosis Autism Severity 
measure 
IQ or Adaptive 
functioning & 
other measures 
SCAS-P total  
Full sample/ 
present study 
870 465 (53.4%) UK 
164 (18.9%) US 
241 (27.7%) SG 
 
Informants: 
Mothers (651, 74.8%)  
Fathers (77, 8.9%),  
Both parents (8, 0.9%),  
Grandparents (1, .1%),  
Others (4, 0.5%)  
Not reported (129, 
14.8%). 
 
9.5% in mainstream 
schools, 31.8 % in 
special schools, 0.1% 
home-schooled, 58.5% 
information not 
available 
 727 (83.6%) Autism/ASD 
  
111 (12.8%) Asperger’s 
syndrome 
 
32 (3.7%) PDD-NOS 
 
Caregiver report or research-
based; all made by qualified 
professionals based on DSM-
IV, DSM-IV-TR or ICD-10 
criteria according to standard 
national procedures for 
diagnosis of ASD in the 
respective countries typically 
including interviews with 
caregivers and child 
observations/ assessment. 
SRS (n=130; 
M=159.2; 
SD=19.13) 
 
SCQ (n=122; 
M=21.33, 
SD=6.56) 
 
DBC-ASA 
(n=238; 
M=18.39; 
SD=9.33) 
 
 
Harmonized 
pooled item mean 
caregiver-
reported autism 
symptom severity 
score (range 0-1; 
n=393; M=0.41; 
SD=0.20)  
IQ scores (M= 
96.58, SD= 20.36, 
Range=13-144, 
n=312) 
 
Adaptive 
functioning SS 
scores (n=239; 
M=58.8; SD=40.4) 
 
Overall 
“functioning” 
classification mean 
ranking score 
(M=4.73, 
SD=2.203, 
(1=lower to 8= 
superior; n=551) 
M=26.58 
SD=17.76 
Range 0 to 94 
1. (Fletcher-
Watson et al., 
2012; 
Rodgers, Glod 
et al., 2012; 
Rodgers, Riby 
et al. 2012) 
 
20  UK community 
sample, not help-
seeking for anxiety 
 
8-16 years old (M= 
153.45 months, 
SD=24.86); 80% Male 
Recruited through database, 
information sent to suitable 
families. 
 
Inclusion: diagnosis of ASD, 
8-16 years old 
Exclusion: taking medication 
for repetitive behaviours 
Diagnosed through 
multidisciplinary team 
assessment following guidelines 
of the UK National Autism Plan 
for Children (Le Couteur, 
2003); confirmed with  SCQ 
 
100% Autism/ASD diagnosis 
 
SCQ  
 
(M=24.80, SD= 
5.07, Range=15-
31) 
 
100% met cut-off 
WISC-III short 
form full IQ 
(M=93.20, 
SD=18.27,  
Range= 69-133) 
M=40.70 
SD=21.50 
Range=9-94 
2. (Maskey et 
al., 2013; 
McConachie 
et al., 2009) 
 
191 UK Community 
sample, not help-
seeking for anxiety 
 
9-15 years old (M= 
147.37 months, 
SD=24.00); 86.4% 
Families given information 
about joining research 
database by diagnosing 
clinicians, other service 
providers, or voluntary 
organisations 
 
Multi-professional diagnostic 
teams (as Study 1); Parent 
report of diagnosis received and 
validated with information 
collected from professionals; 
most children known to local 
services and diagnosis 
No additional 
measure 
administered as 
part of the study  
Not measured as 
part of this study 
M=33.38 
SD=19.82 
Range=0-86 
Male Inclusion: diagnosis of ASD; 
Any age to 18 years.  
confirmed by professionals  
 
75.4% Autism/ASD 
24.6% Asperger’s syndrome 
 
 
3. 
(McConachie 
et al., 2013) 
21 UK clinical sample 
help-seeking for 
anxiety 
 
8-13 years old 
(M=137.05 months, 
SD=16.22); 95.2% 
Male 
Approached by member of 
CAMHS team 
 
Inclusion: diagnosis of ASD, 
at least 2 anxiety disorders; 9 
to 13 years 11 months; Full 
IQ>69; 
Exclusion: untreated ADHD 
or oppositional behaviors 
Multi-professional diagnostic 
team, confirmed by ADOS 
Module 3 and SCQ. 
 
100% Autism/ASD 
ADOS diagnostic 
algorithm score  
(n= 20; M=10.35, 
SD=3.79, 
range=5– 19) 
 
85% (17 out of 
20) met cut-off 
WASI full score  
 
(n=19; M=103.74, 
SD = 15.23, 
Range= 70-121) 
M=40.90 
SD=18.57 
Range=7-75 
4 (Boulter et 
al., 2014; 
Chamberlain 
et al., 2013; 
South et al., 
2014; 
Wigham et al., 
2015) 
65 US research sample, 
not help-seeking for 
anxiety 
 
7-18 years old 
(M=154.32 months, 
SD=31.87); 92.3% 
Male 
Inclusion: Research diagnosis 
of ASD & FSIQ > 80; aged 8-
18 years 
Research diagnosis of ASD, and 
above cut-off in SRS 
 
100% Autism/ASD 
ADOS diagnostic 
algorithm score 
(n= 62; M= 
11.68, SD=3.57, 
Range= 7-20) 
 
SRS Total Score 
(n= 59), M=104, 
SD= 23.18, 
Range=55-149 
WASI (n=43; 
M=110.53, 
SD=13.78, Range= 
84-140) 
M=28.22 
SD=18.52 
Range=2-87 
5 (Boulter et 
al., 2014) 
19 UK Community and 
research database, not 
help seeking for 
anxiety 
 
8-15 years old 
(M=139.74 months, 
SD=29.66); 84.2% 
Male 
Recruited through DASLnE 
database 
 
Inclusion: 8-18 years old with 
ASD or Asperger’s syndrome 
As in Study 1 
 
100% Autism/ASD 
 
No formal 
measure 
administered as 
part of this study 
WASI (n=14; 
M=101.93, 
SD=11.55, 
Range=83-119) 
M=25.21 
SD=18.49 
Range=3-62 
6. Darus 
(2016)  
34 UK community 
sample, not help 
seeking for anxiety 
 
7-17 years old 
(M=139.50 months, 
SD=35.90); 85.3% 
Male 
Recruited from mainstream 
and special schools 
 
Inclusion: age 8-16 years old 
with ASD or Asperger’s 
syndrome 
Based on SRS and parent 
reported diagnosis 
 
58.8% Autism 
41.2% Asperger’s syndrome 
 
SRS 
(n=32; 
M=162.55, SD= 
20.19, Range = 
116-202) 
 
100% (32 out of 
32) met cut-off 
WASI  
 
(M=83.29, SD= 
12.42, Range= 64-
116) 
M=32.88 
SD=17.21 
Range=1-68 
7 (Magiati et 
al., 2014; 
Magiati et al., 
241 Singapore  
Unselected community 
sample;  
Recruited from special 
schools 
 
Parent- report and special 
school formal entry criteria; all 
professional diagnosis;  
DBC-Autism 
Screening 
Algorithm score  
Adaptive behaviour 
SIB-R (n=239; 
M=58.83, 
M=18.23 
SD=11.23 
Range=0-63 
2016; Zainal 
et al., 2014) 
 
5-17 years old 
(M=123.58 months, 
SD=35.88); 81.7% 
Male 
Inclusion: age range 6-18 
years old; diagnosis of 
Asperger’s Syndrome, ASD, 
Autism/ Autistic disorder, 
PDD-NOS by professional  
 
91.7% Autism; 6.2% 
Asperger’s syndrome; 2.1% 
PDD-NOS  
 
DBC-Autism Algorithm 
(M=18.4, SD=9.3, range=0-41) 
(n=238; 
M=16.23, 
SD=8.34, 
Range=0-42) 
 
68.1% (162 out of 
238) > cut-off of 
14 
SD=40.37, Range= 
0-171) 
 
DBC-Anxiety 
subscale (n=238; 
M=4.66, SD=2.96, 
Range=0– 15) 
 
DBC-
disruptive/antisocia
l subscale (n=238; 
M=12.54, SD=7.76, 
Range=0-34) 
8. (Hollocks 
et al., 2014; 
Mikita et al., 
2015) 
53 Recruited from 
CAMHS  
 
10-16 years old 
(M=154.19 months, 
SD=22.99); 100% 
Male 
IQ ≥ 70 on WASI 
and with good verbal ability 
 
ASD diagnosed by Multi-
disciplinary Team in CAMHS 
services; 31 out of 52 based on 
ADOS/ADI used by local team, 
otherwise clinical diagnoses 
confirmed by SCQ; 100% ASD 
 
No scores 
available for the 
study, but clinical 
diagnoses used 
ADOS/ ADI or 
SCQ. 
WASI  
 
(M=101.42, 
SD=13.20, 
Range=76– 138) 
M=33.11 
SD=19.51 
Range=3-88 
9. (Hollocks 
et al., 2013) 
 
32 Special schools 
 
10-17 years old 
(M=157.78 months, 
SD=16.65); 100% 
Male  
IQ ≥ 70 on WASI and a score 
of ≥ 70 on the WIAT 
 
SCQ; 100% Autism 
 
SCQ 
(M=22.78, 
SD=7.50, 
Range=6– 35) 
 
87.5% (28 out of 
32) met cut-off 
WASI 
(M=96.19, 
SD=13.65, 
Range=73– 122) 
 
M=25.74 
SD=16.11 
Range=6-64 
10. (Lidstone, 
Uljarevic et 
al., 2014) 
 
95 Recruited through local 
schools with specialist 
autism provision and 
parent support groups.   
 
6 to 18 years old 
(M=137.17 months, 
SD=40.90); 98.9% 
Male 
Clinical diagnosis of ASD 
established by 
multidisciplinary clinical 
team. 
 
Exclusions: brain injury, 
cerebral palsy, any neuro/ 
musculo/ skeletal disorder/ 
malformation that would 
seriously limit ability to walk 
without help or a known 
genetic condition (e.g., Fragile 
X, Down syndrome). 
 
N= 63 recruited from Ireland 
and N= 32 from South Wales 
ASD diagnosed by 
multidisciplinary diagnostic 
team. Clinicians from two 
health boards involved in 
diagnosing children confirmed 
DSM-IV-TR diagnosis –ADOS 
routinely used in these services. 
 
63.2% Autism; 36.8% 
Asperger’s syndrome 
SCQ 
(n=28;M=21.35, 
SD=4.12, 
Range=12– 31) 
 
92.9% (26 out of 
28) met cut-off 
No formal 
measures; 
Parent report of 
language level 
based on the 
Diagnostic 
Interview for Social 
and 
Communication 
Disorders (DISCO) 
expressive 
language scale 
M=29.39 
SD=17.21 
Range=1-75 
11. (Parker et 
al., 2014) 
56 Children with ASD 
recruited through the 
3-12 year old children with 
ASD who met ADOS and 
ASD diagnosis based on 
ADOS, ADI-R and expert 
SRS (n=55; 
M=154.27, 
Stanford Binet 5th 
Ed. (n=54; 
M=16.28 
SD=10.44 
  Autism and 
Developmental 
Disorders Research 
Registry and by flyers 
posted in the Autism 
and Developmental 
Disorders Clinic at 
Stanford University 
 
6 to 12 years old 
(M=114.79 months, 
SD=23.43); 80.4% 
Male 
. 
ADI-R diagnostic criteria.  
All participants were (i) pre-
pubertal, (ii) in good medical 
health, and (iii) willing to 
provide a blood sample. 
Participants included if they 
had a full-scale IQ >50 and no 
genetic conditions 
clinical opinion.  
 
51.8% Autism; 48.2% PDD-
NOS 
SD=18.64, 
Range=100-205) 
 
ADOS diagnostic 
algorithm score  
 (n=51, M= 14.51, 
SD=5.21, 
Range=3-24) 
 
100% (55) met 
SRS cut-off, but 
94% (48) met 
ADOS cut-off 
 
M=79.33, 
SD=26.12, 
Range=13– 128; 
N=54) 
Range=3-52 
12. (Schohl et 
al., 2014; 
Vaughan Van 
Hecke et al., 
2015) 
43 RCT Community  
sample recruited via in-
house waiting list for 
social skills treatment 
at University Autism 
Clinic (not selected for 
anxiety); assessed at 3 
time points: before and  
after intervention, and 
at 6-months follow-up 
 
11 to 16 years old 
(M=161.02 months, 
SD=16.82); 83.7% 
Male 
(a) aged between 11 and 16 
years old; (b) fluent in 
English; (c) no history of 
adolescent major mental 
illness, such as bipolar, 
schizophrenia, or psychosis; 
(d) no history of hearing, 
visual, or physical 
impairments; (e) adolescent 
wants to learn to make and 
keep friends; (f) KBIT Verbal 
IQ > 70 
Established community 
diagnosis by professional of 
either Autism, Asperger, or 
Pervasive Developmental 
Disorder—NOS; and meeting 
criteria for ASD or Autism on 
the ADOS-G Module 4 
 
100% ASD on ADOS 
ADOS diagnostic 
algorithm score  
 (M=10.16, 
SD=3.27, 
Range=7– 18) 
 
SCQ 
(n=42; M=17.90, 
SD=6.38, 
Range=3-30) 
 
SRS (M=163.16, 
SD=18.17, Range 
= 125 – 199) 
 
100% met ADOS 
and SRS cut-off 
Kaufman Brief 
Intelligence Test-
Second Edition  
(M=105.79, 
SD=19.28, 
Range=71– 144) 
M=22.51 
SD=14.55 
Range=4-66 
SCQ = Social Communication Questionnaire (Rutter et al., 2003); SRS = Social Responsiveness Scale (Constantino & Gruber, 2005); ADOC = Autism Diagnostic Observation Schedule; 
ADI-R = Autism Diagnostic Interview – Revised; DBC = Developmental Behaviour Checklist; WISC-III = Wechsler Intelligence Scale for Children Third Edition; WASI = Wechsler 
Abbreviated Scale of Intelligence; KBIT = Kaufman Brief Intelligence Test; FSIQ= Full Scale Intelligence Quotient; SIB-R = Scales of Independent Behavior-Revised; Daslne= Database of 
Children with Autism Spectrum Disorder Living in the North East; SLaM = South London and Maudsley NHS Foundation Trust; CAMHS = Child and Adolescent Mental Health Services in 
UK.  
  
 Table 3. Descriptive statistics for variables and comparison among country subsamples (n=849; excluding the 21 participants from the clinically anxious subsample) 
Variables Mean (SD) /  Mode# Welch ANOVA / Chi-
square# 
Effect 
size, η 
p Post-hoc 
analyses 
Effect 
size, d 
UK US Singapore  
 
 
 
 
 
 
 
 
Age in months 146.10 (29.75) 142.58 (32.66) 123.58 (35.88) F (2, 381.43)=34.93 0.29 
 
<.001*** UK=US>SG .11-.68 
SCAS-P total raw score 31.89 (18.99) 22.64 (15.89) 18.23 (11.23) F(2, 425.50)=69.96 0.35 
 
<.001*** UK>US>SG .32-.88 
SRS total raw score 162.28 (19.91) 
n=32 
158.17 (18.87) 
n=98 
-  -    
SCQ total raw score 23.12 (5.94) 
n=80 
17.90 (6.34) 
n=42 
-  -    
DBC-Autism Screening 
Algorithm 
- - 18.29 (9.33) 
n=238 
- - - - - 
Caregiver-reports ASD 
symptom harmonized 
mean score + 
0.59 (0.13) 
n=112 
0.45 (0.16) 
n=42 
1.31 (0.16) 
n=238 
F(2, 109.10)= 147.46 0.63 
 
<.001*** UK>US>SG 0.86-
1.90 
Overall  Functioning 
Classification ranking++#  
5.71 (1.18) 
N=153 
5.73 (1.79) 
N=140 
[adaptive 
functioning] 
3.40 (2.28) 
N=239 
χ2 (2, N = 532) = 192.60 0.60 
 
<.001*** US=UK>SG  0.013-
1.28 
Gender# Male Male Male χ2 (2, N = 849) = 13.27 0.13 .001*** -  
#mode value and chi-square test for gender; + see Methods, Statistical plan; lower score indicates less severe symptoms; range 0-1; ++ see Methods, Statistical Plan; functioning classification 
range 1 (lower functioning) to 8 (superior functioning); * p<.05; ** p<.01; *** p<.001. SRS=Social Responsiveness Scale; SCQ=Social Communication Questionnaire.  
 
Table 4. Descriptive statistics for variables and comparison among participants meeting and not meeting ASD cut-off (n=849; excluding the 21 help-seeking for anxiety participants) 
Variables 
 
 
Mean (SD) /  Mode# Welch ANOVA /  
Chi-square# 
Effect size, η p 
Meeting ASD 
screening cut-
off (n=376) 
Not meeting ASD 
screening cut-off/ no 
ASD screening score 
available (n=473) 
 
 
 
Age in months 132.57 (34.19) 144.16 (32.22) F(1, 781.71)= 25.34 0.17 <.001
*** 
SCAS-P Total raw score 23.96 (15.60) 28.02 (18.88) F(1, 845.74)= 11.78 0.11 .001** 
SCAS-P Panic  3.14 (3.46) 3.58 (4.08) F(1, 843.49)= 2.97 0.058 .085 
SCAS-P Separation Anxiety  4.34 (3.60) 4.87 (3.90) F(1, 828.43)= 4.21 0.070 .040 
SCAS-P Physical Injury  4.42 (2.90) 4.46 (3.09) F(1, 823.94)= 0.40 0.0068 .841 
SCAS-P Social Phobia  4.37 (4.02) 6.12 (4.75) F(1, 843.55)= 33.61 0.19 <.001
*** 
SCAS-P OCD  3.46 (3.19) 3.96 (3.83) F(1, 845.16)= 4.30 0.070 .038 
SCAS-P GAD  4.24 (3.20) 5.04 (3.68) F(1, 840.01)= 11.37 0.11 .001 
Overall  Functioning Classification 
ranking++#  
4.24 (2.28)/  
6 “average” 
[n=347] 
5.49 (1.8)/  
6 “average” 
[n=185] 
χ2 (1, N = 532) = 50.50 
 
0.31 
 
<.001*** 
Gender# 1.16 (.36) 
Male 
1.10 (.30) 
Male 
χ2 (1, N = 849) = 6.35 0.086 .012* 
#mode value and chi-square test for gender and Overall Functioning classification; ++ see Methods, Statistical Plan; classification range 1 (lower functioning) to 8 (superior functioning); * 
p<.05; ** p<.01; *** p<.001.  
  
  
Table 5. Descriptive statistics, subscale-total correlations and internal consistency of original and PCA-derived SCAS-P full scale and subscales  
SCAS-P Pooled 
sample’s#  
Mean (SD) 
Pooled 
sample’s 
Item Mean 
(SD) 
Corrected 
subscale-total 
correlations 
Cronbach’s α Normative means 
(SD) from Nauta et 
al. (2004) 
One sample t-
test comparison 
of study’s mean 
with norms 
Effect 
size, d 
Original 38-item SCAS-P        
Panic and Agoraphobia 3.38 (3.82) 0.38 (0.43) .76 .83 1.0 (1.6) t(848)=18.19* 0.81 
Separation anxiety 4.63 (3.78) 0.78 (0.63) .74 .76 2.6 (2.8) t(848)=15.67*  0.61 
Physical Injury 4.44 (3.01) 0.89 (0.60) .49 .55 2.6 (2.3) t(848)=17.83*  0.69 
Social Phobia 5.34 (4.52) 0.90 (0.76) .67 .84 4.2 (2.8) t(848)=7.36*  0.30 
Obsessive-compulsive disorder 3.74 (3.57) 0.63 (0.60) .67 .80 1.1 (1.7) t(848)=21.55* 0.94 
Generalized anxiety  
 
4.68 (3.50) 0.79 (.59) .82 .82 2.7 (2.0) t(848)=16.50* 0.70 
Total score 26.22 (17.61) 0.70 (0.47) - .93 
 
14.2 (9.7) t(848)=19.90* 0.85 
Revised PCA derived 30-item 
SCAS-P 
       
Somatic/Panic 2.60 (3.52) 0.33 (0.44) .71 .86    
Separation Anxiety 4.54 (3.34) 0.92 (0.68) .58 .76    
Specific Phobias 2.61 (2.50) 0.66 (0.63) .62 .69    
Mixed Social/ Generalized  
Anxiety  
8.17 (6.29) 0.92 (0.70) .66 .90    
Obsessive-compulsive  
 
2.07 (2.43) 0.52 (0.61) .53 .75    
Total score 19.99 (14.17) 0.68 (0.48) - .93    
 *statistically significant if p< (.05/13) = <.0038; #all participants without clinical subsample (n=849). 
  
 Table 6. Correlations between child characteristics and participants’ original SCAS-P scores and PCA-derived 30 item SCAS-P score 
 1 2 3 4 5 6 7 8 9 10 11 
1. Age in months   .036 .249*** 0.172*** .142*** .069* -.022 -.020 .168*** .150*** .280*** 
2. Child's Gender#@ .036  .205 -.039 .016 .025 .007 .031 .038 -.013 -.004 
3. Overall Functioning Classification+ .249*** .205  .045 .165*** .013 .037 -.058 .075 .288*** .370*** 
4. ASD symptom harmonized mean 
score across all caregiver-reported 
measures 
.172*** -.039 .067  .487***1 .445*** .356*** .155** .427*** .440*** .395*** 
5. SCAS-P Total score%$  .137*** .016 .188*** .166***  .846*** .826*** .613*** .774*** .881*** .797*** 
6. Panic and agoraphobia% /  
Somatic and Panic$ subscale 
.076* .030 .086* .077 .820***  .629*** .428*** .625*** .743*** .579*** 
7. Separation anxiety%$subscale 
-
.153*** 
-.004 -.004 -.046*** .728*** .502***  .490*** .567*** .671*** .561*** 
8.  Physical Injury% / Specific Phobia$ 
subscale 
.057 .017 -.016 -.053*** .720*** .529*** .486***  .343*** .427*** .354*** 
9. OCD subscale%$ .129*** .052 -.062 -.091* .650*** .522*** .383*** .402***  .653*** .495*** 
10. GAD% / Mixed GAD & Social 
Phobia$ subscale 
.277*** -.005 .400*** .414*** .873*** .610*** .487*** .517*** .425***  
.677*** 
 
11. Social Phobia% subscale - - - - - - - - - -  
 *p<.05; **p<.01; ***p<.001; #biserial correlations between gender and other continuous variables; @Cramer’s V correlation between gender and overall functioning classification;+Spearman’s 
rho between overall functioning classification and other continuous variables; %original SCAS-P subscale; $PCA-derived SCAS-P subscale. The values above the diagonal line correspond to 
the correlations between the child characteristics and original SCAS-P total and subscales scores, while the values below the diagonal line correspond to the corrections between the child 
characteristics and PCA-derived SCAS-P total and subscales scores.   
  
                                                          
1 Correlations between the total raw scores of the caregiver reported autism symptom measures and the SCAS-P total score were also similar to the relationship reported for the harmonized 
mean: SRS r=.44; SCQ r=. 35; DBC-ASA r=. 38, all p<.01.  
  
Table 7. Comparison between referred (n=21) and unselected subsamples  
Variable Mean (SD) for 
clinical 
subsample 
(n=21) 
Mean (SD) for 
unselected 
subsample 
(n=849) 
Welch ANOVA Effect 
size, d 
p 
Original SCAS-P      
Panic & Agoraphobia 5.57 (4.57) 3.38 (3.82) F (1, 20.70)=4.73 0.52 
 
.041 
Separation Anxiety 6.71 (4.48) 4.63 (3.78) F(1, 20.71)=4.44 0.50 .047 
Physical Injury 5.71 (3.38) 4.44 (3.01) F(1, 20.79)=2.93 0.40 .102 
Social Phobia 8.76 (4.07) 5.34 (4.52) F(1, 21, 24)=14.36 0.79 .001* 
OCD 6.00 (3.46) 3.74 (3.57) F(1, 21.06)=8.72    0.64 .008 
GAD 8.14 (3.61) 4.68 (3.50) F(1, 20.94)=18.86 0.97 <.001* 
Total 40.90 (18.57) 26.22 (17.61) F(1, 20.90)=12.85 0.81 .002* 
Revised PCA-derived 
SCAS-P 
     
Somatic/Panic 4.43 (4.13) 2.60 (3.52) F(1, 20.73)=4.03 0.48 .058 
Separation Anxiety 6.86 (4.52) 4.54 (3.34) F(1, 20.54)=5.47 0.58 .030 
Specific Phobias 3.57 (3.20) 2.61 (2.50) F(1, 20.61)=2.76 0.33 .187 
Mixed Social/ GAD 13.19 (4.93) 8.17 (6.29) F(1, 21.64)=20.99 0.89 <.001* 
OCD 2.95 (2.40) 2.07 (2.43) F(1, 21.03)=2.76 0.36 .111 
Total  31.00 (14.69) 19.99 (14.17) F(1, 20.93)=11.53 0.76 .003* 
*statistically significant if p< (.05/13) = <.0038. 
 
 
 
 
 
 
 
 
Table 8. Summary of Confirmatory Factor Analyses for the SCAS-P 
 
Model X2 df CFI TFI RMSEA (90% 
CI) 
Model Comparison* 
Null Model 11574 703 - - - - 
Model 1: 1 Factor 4055 665 0.69 0.67 0.077 (0.074 -
0.079) 
X2 (df) = 3470 (38) , p 
≤ .01 
Model 2: 6 uncorrelated 
factors 
5151 665 0.59 0.56 0.101 (0.099 – 
0.103) 
N.S. 
Model 3: 6 correlated factors  2952 650 0.79 0.77 0.064 (0.061 – 
0.066) 
X2 (df) =1103 (15) , p 
≤ .01 
Model 4: 5 factors and GAD 
as a second order factor 
3127 661 0.77 0.76 0.065 (0.063 – 
0.068) 
X2 (df) =175 (11) , p ≤ 
.01 
Replication of PCA model 
in the other subsample 
(n2=424) 
4242 663 0.67 0.65 0.079 (0.077 -
0.081) 
- 
 *Satorra- Bentler scaled χ2 vs. the previous model; CFI=Comparative Fit Index, TFI= 
Tucker-Lewis Fit index; RMSEA=Root Mean Square Error of Approximation. 
 
 
 
 
 
 
  
  
Table 9. Pattern Matrix derived from Principal Component Analysis (PCA) 
SCAS-P Items 
 
Components 
Mixed 
Social/ 
GAD 
Separation 
anxiety 
Somatic / 
Panic 
symptoms 
OCD Specific 
Phobias 
26. worries what other people think of 
him/her 
.840     
9. afraid that (s)he will make a fool of 
him/herself in front of people 
.796     
10. worries that (s)he will do badly at school .785     
31. feels afraid when (s)he has to talk in 
front of the class 
.664     
6. scared when s(he) has to take a test .650     
11. worries that something awful will 
happen to someone in our family 
.603     
1. worries about things .579     
20.  worries that something bad will happen 
to him/her 
.452     
15. trouble going to school in the mornings .397     
14. scared if (s)he has to sleep on his/her 
own 
 .789    
2. scared of the dark  .735    
5. afraid of being on his/her own at home  .683    
8. worries about being away from us / me  .492    
4. complains of feeling afraid  .443    
32. complains of his / her heart suddenly 
starting to beat too quickly for no reason 
  -.759   
18. s(he) complains of his/her heart beating 
really fast 
  -.756   
12. complains of suddenly feeling as if (s)he 
can't breathe 
  -.755   
30. suddenly becoming dizzy or faint   -.702   
19. starts to tremble or shake   -.687   
22. (s)he feels shaky   -.626   
28. child feels really scared for no reason at 
all 
  -.490   
33. worries that (s)he will suddenly get a 
scared feeling when there is nothing to be 
afraid of 
  -.476   
35. has to do some things over and over 
again 
   .800  
37. has to do certain things in just the right 
way to stop bad things from happening 
   .797  
13. keep checking that (s)he has done things 
right 
   .620  
24. has to think special thoughts to stop bad 
things from happening 
   .596  
27. afraid of being in crowded places     .684 
21. scared of going to the doctor or dentist     .621 
7. afraid when (s)he has to use public toilets     .545 
25.  feels scared if (s)he has to travel in the 
car, or on a bus or train 
    .541 
This analysis was conducted using half of the unselected subsample randomly selected (n=425).  
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